Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis

Michael A Ko1, Carla O Rosario, John W Hudson

  • 1Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Ave. R988, Toronto, Ontario M5G 1X5, Canada.

Nature Genetics
|July 19, 2005
PubMed

Insights

Reduced polo-like kinase 4 (Plk4) gene dosage in mice leads to increased cancer risk. Plk4 haploinsufficiency causes mitotic errors, aneuploidy, and accelerates hepatocellular carcinogenesis, highlighting Plk4

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Polo-like kinase 4 (Plk4) is essential for mitotic progression, cell survival, and embryonic development.
  • Plk4's role in maintaining genomic stability and its implications in cancer development are not fully understood.

Purpose of the Study:

  • To investigate the phenotypic consequences of Plk4 haploinsufficiency in cellular and animal models.
  • To determine the impact of reduced Plk4 gene dosage on mitotic fidelity, cell cycle regulation, and cancer development.

Main Methods:

  • Analysis of Plk4 heterozygous (Plk4+/-) embryonic fibroblasts and mice.
  • Assessment of centrosomal amplification, spindle formation, and aneuploidy.
  • In vivo partial hepatectomy model to study cell cycle regulation in regenerating liver.
  • Evaluation of cyclin and Cdk1 regulation, p53 activation, and expression of p21 and BubR1.
  • Analysis of spontaneous tumor incidence and loss of heterozygosity at the PLK4 locus in human hepatoma.

Main Results:

  • Plk4+/- cells exhibited increased centrosomal amplification, multipolar spindles, and aneuploidy.
  • Plk4+/- mice showed a 15-fold higher incidence of spontaneous liver and lung cancers.
  • Impaired regulation of cyclins D1, E, B1, and Cdk1, suppressed p53 activation, p21, and BubR1 expression in Plk4+/- regenerating liver.
  • Defects led to progressive cell cycle delays, spindle irregularities, and accelerated hepatocellular carcinogenesis.
  • Frequent loss of heterozygosity at the PLK4 locus in human hepatoma suggests a similar mechanism.

Conclusions:

  • Plk4 haploinsufficiency compromises mitotic fidelity and cell cycle control, leading to genomic instability.
  • Reduced Plk4 gene dosage significantly increases susceptibility to cancer, particularly hepatocellular carcinoma.
  • These findings underscore the critical role of Plk4 in preventing cancer development and highlight the clinical relevance of PLK4 locus alterations in human hepatoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...